1 / 4

CAR T Cell Therapy Market Research Report - Global Forecast till 2025

CAR T Cell Therapy Market Research Report - Global Forecast till 2025 - Shortcut

Rohitravan
Télécharger la présentation

CAR T Cell Therapy Market Research Report - Global Forecast till 2025

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. “Global CAR T cell Therapy MarketResearch Report - Forecast till 2025”– Market Analysis, Scope, Stake, Progress, Trends and Forecast to 2025. Global CAR T cell Therapy Market is projected to reach USD 8716.06 Million by 2025 at a CAGR of 58.52% during the review period from 2019 to 2025. Chimeric Antigen Receptor (CAR) T Cell Therapy is an immunotherapy used for cancer treatment. In this therapy, T cells from patient body are isolated and inserted in the CAR gene so that the gene for the specific receptor binds to a certain protein on the patient’s cancer cells. Growing prevalence of cancer across the world, technological advancement for advanced & reliable treatment for cancer, and rise in the number of cell therapy clinical studies are driving the growth of the global CAR T Cell Therapy market. According to the National Cancer Institute, it is estimated that 1,735,350 new cases of cancer were diagnosed, and 609,640 deaths were reported in the US in 2018. Moreover, the growing pharmaceutical industry is also expected to boost market growth. Avail a Free Sample@ https://www.marketresearchfuture.com/sample_request/2753 Segment Analysis The global CAR T cell therapy market, by target antigen, has been segmented into CD19, CD22, and others. The CD19 target antigen segment accounted for a value of USD 342.56 million in 2018. On the basis of application, the global CAR T cell therapy market is segmented into acute lymphoblastic leukemia, diffuse large B-cell lymphoma, and others. Market Players Market Research Future (MRFR) recognizes the following companies as key players in the global CAR T Cell therapy market that include Novartis AG (Switzerland), Pfizer, Inc. (US), Kite Pharma (US), Cellectis (France), Autolus Therapeutics PLC (UK), CARsgen Therapeutics (China), Juno Therapeutics (US), Sorrento Therapeutics (US), Legend Biotech (US), Mustang Bio (US), and others. Market Research Future

  2. Access therapy-market-8102 Report Details @ https://www.marketresearchfuture.com/reports/car-t-cell- Regional Analysis The global CAR T cell therapy market, based on region, is divided into the US, Europe, China, and the rest of the world. The US is expected to hold the largest share of the global CAR T cell therapy market. This is owing to the increasing cases of cancer in the country. Europe showed a considerable amount of growth in the market due to an increase in the occurrences of hematologic cancer such as leukemia, lymphoma, and multiple myeloma. Europe held a market share of 9.15% in the global CAR T cell therapy market. China is estimated to significantly grow in the global market due to the developing healthcare infrastructure and increasing disposable income. Also, the market in the Middle East & Africa is expected to show the least growth owing to limited healthcare access and affordability among the population. Key Findings of the Study The Global CAR T cell Therapy Market is projected to reach USD 8716.06 Million by 2025 at a CAGR of 58.52% during the review period from 2019 to 2025. • The US accounted for the largest share of the global market due to the rising prevalence of cancer in the country. • The CD19 target antigen accounted for the largest target antigen segment, with a revenue of USD 56 million in 2018. • Avail an Amazing Discount@ https://www.marketresearchfuture.com/check-discount/2753 Market Research Future

  3. How can we help you? We help you with this process and guide you the exact way to look for with our studies and analysis related to the same. Contact Us Contact AKASH ANAND Domain Head - Business Development +1 (646) 843 9312 (US) +44 208 133 9349 (UK) ABU KOSHY Domain Head - Business Development +1 339 368 6938 The report also appraises the supervisory scenarios which affect various decisions in the market. With all the data congregated and scrutinized using SWOT analysis, there is a vibrant picture of the competitive scenario of the Global Keratoacanthoma Market Size. Market Research Future

  4. Openings for the future market growth were uncovered and preoccupied competitive threats also textured. About Market Research Future: MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions. Contact: Market Research Future +1 646 845 9312 Email: sales@marketresearchfuture.com Market Research Future

More Related